The role of cytochrome P450 2D6 in the metabolism of moclobemide
- 31 August 1996
- journal article
- Published by Elsevier BV in European Neuropsychopharmacology
- Vol. 6 (3), 225-230
- https://doi.org/10.1016/0924-977x(96)00023-5
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Role of cytochrome P4502D6 in the metabolism of brofaromineEuropean Journal of Clinical Pharmacology, 1993
- An update of recent moclobemide interaction dataInternational Clinical Psychopharmacology, 1993
- The role of individual human cytochrpmes P450 in drug metabolism and clinical responseTrends in Pharmacological Sciences, 1992
- Influence of food on the tyramine pressor effect during chronic moclobemide treatment of healthy volunteersEuropean Journal of Clinical Pharmacology, 1992
- Interactions of moclobemide with concomitantly administered medication: evidence from pharmacological and clinical studiesPsychopharmacology, 1992
- Clinical consequences of polymorphic drug oxidationFundamental & Clinical Pharmacology, 1991
- Relevance of genetic polymorphism in drug metabolism in the development of new drugsEuropean Journal of Clinical Pharmacology, 1989
- Debrisoquine oxidative phenotyping and psychiatric drug treatmentEuropean Journal of Clinical Pharmacology, 1989
- Characterization of the common genetic defect in humans deficient in debrisoquine metabolismNature, 1988
- Determination of the new monoamine oxidase inhibitor moclobemide and three of its metabolites in biological fluids by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1987